Samir Kanani, MD
Radiation Oncology · Fairfax, VANPI 1558336719
Payments from drug & device makers
What this record shows
This record is dominated by speaking fees: $72,350 of the $89,891 with a category attached, or 80.5%. Novocure Inc. accounts for 96.7% of it on its own, with 23 other manufacturers making up the rest. Reporting peaked in 2022 at $18,789 and has fallen 95.3% since, to $881 in 2025. Among radiation oncology clinicians in VA with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 154 payments — averaging $583.71 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Novocure Inc.$87K
- Boston Scientific$609
- Palette Life Sciences, Inc.$528
- Teleflex LLC$289
- Integra Lifesciences Corporation$166
- Medtronic$140
- plus $1K from 18 others
What the payments were for
- Consulting fees$3,9004%
- Speaking & faculty fees$72,35080%
- Travel & lodging$7,7229%
- Food & beverage$5,8146%
- Education$1050%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Novocure Inc. | 111 | $86,940 |
| Boston Scientific | 5 | $609 |
| Palette Life Sciences, Inc. | 4 | $528 |
| Teleflex LLC | 3 | $289 |
| Integra Lifesciences Corporation | 1 | $166 |
| Medtronic | 2 | $140 |
| GT Medical Technologies, Inc | 1 | $139 |
| Isoray, Inc | 1 | $138 |
| Myriad Genetic Laboratories, Inc. | 1 | $125 |
| Novartis | 5 | $108 |
| Sumitomo Pharma America, Inc. | 1 | $102 |
| Merck | 4 | $92 |
| Progenics Pharmaceuticals, Inc. | 1 | $90 |
| Myovant Sciences Inc. | 1 | $83 |
| Regeneron Healthcare Solutions, Inc. | 3 | $65 |
| Pharmaessentia USA Corporation | 2 | $56 |
| Bioprotect Medical, Inc. | 1 | $39 |
| Sirtex Medical Inc | 1 | $37 |
| Beone Medicines USA, Inc. | 1 | $30 |
| Astellas Pharma US Inc | 1 | $29 |
| Bayer | 1 | $27 |
| Lilly USA, LLC | 1 | $23 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $21 |
| Angiodynamics, Inc. | 1 | $15 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Optune$51,573
- Oncology$34,290
- SpaceOAR VUE System - 10mL$252
- Barrigel$242
- GENERAL ONCOLOGY$183
- CODMAN CERTAS$166
- CUSA CLARITY$166
- CODMAN HAKIM$166
- DURASEAL EXACT SPINAL SEALANT SYSTEM$166
- GENERAL - THERAPIES$146
- GammaTile$139
- Brachytherapy Source$138
- OSTEOCOOL RF ABLATION SYSTEM$126
- BRAC CDx$125
- ORGOVYX$102
How this compares
$89,891 in reported general payments places this provider in the 95th percentile of 121 radiation oncology providers in Virginia.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other radiation oncology in Fairfax
- Daniel KimFairfax$406K
- Gopal BajajFairfax$23K
- Ashish ChawlaFairfax$14K
- Gregory SibleyFairfax$10K
- Kevin ChoeFairfax$8K
- Harold AgbahiweFairfax$7K
- Lonika MajithiaFairfax$5K
- Tobias ChapmanFairfax$2K
- Kathryn MarqueenFairfax$2K
- Michael EblanFairfax$1K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.